ACHV
HealthcareAchieve Life Sciences, Inc.
$5.19
+$0.22 (+4.43%)
Jan 5, 2026
Price History (1Y)
Analysis
Achieve Life Sciences, Inc. is a biotechnology company in the healthcare sector with a market capitalization of $276.28M and 25 employees. The company has negative profitability, with gross margin, operating margin, and profit margin all at 0.0%. Achieve Life Sciences also has negative returns on equity (-161.1%) and assets (-65.5%). The balance sheet shows debt of $9.96M against cash reserves of $48.11M, resulting in a debt-to-equity ratio of 29.62. The company's valuation is characterized by negative P/E ratios (TTM: N/A, Forward: -4.42) and a price to book ratio of 8.16. The Enterprise Value to EBITDA multiple is also negative (-4.34). Achieve Life Sciences does not pay dividends, with a payout ratio of 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Visit website →Key Statistics
- Market Cap
- $276.28M
- P/E Ratio
- N/A
- 52-Week High
- $5.78
- 52-Week Low
- $1.84
- Avg Volume
- 1.20M
- Beta
- 1.72
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 25